The last thing patients want is to be put on hold or interrupted by calls at work.
Panelists discuss how dose modifications for ALK inhibitors can significantly improve quality-of-life issues such as brain fog and weight gain while maintaining disease control, emphasizing the importance of multidisciplinary team support, including palliative care from diagnosis.
The rise of social media platforms has helped foster a community for adolescent and young adult patients with cancer.
An expert explores the complexities of immunotherapy during pregnancy, highlighting risks to the fetus and the crucial role of oncology nurses in patient education and management.
Kara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Patients with intermediate- or high-risk MDS experienced a higher modified overall response rate with the venetoclax/azacitidine vs placebo/azacitidine.
In addition to a significant PFS benefit vs nab-paclitaxel alone, the combination provides an at-home option for patients with ovarian cancer.
Longer duration of CDK4/6 inhibitor prior to treatment with elacestrant correlated with progression-free survival (PFS) improvements in patients with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer vs standard-of-care options.
Jessie Desir, PhD, RN, AMB-BC, OCN, explained that comprehensive disease and treatment education are essential to adherence for patients with breast cancer.
Meredith Cummings BSN, RN, OCN, highlights her research on machine learning and its potential application in optimizing symptom management.
Tebentafusp, the first FDA-approved treatment option for patients with unresectable or metastatic uveal melanoma, may cause mild cytokine release syndrome, an expert explains.
The intersection of cardiology and oncology is greater than nurses and providers may assume, explained 2 experts.
Eric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, describes disseminated intravascular coagulation and best nursing strategies to mitigate the severity of this condition.
A program evaluated at Michigan State University has shown that meditation helps combat burnout and promote well-being among health care workers, particularly in hospice settings.
As with all patients with cancer, providing care for those with lung cancer involves both physiological and psychological aspects.
Because oncology nurses are at the forefront of patient care, they are uniquely positioned to facilitate cancer survivorship and lymphedema prevention.
Understanding psychosocial implications, barriers, risks, and impacts.
La-Urshalar Brock, FNP-BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in patients with breast cancer.
“This is a holistic, functional and integrative approach to your mental well-being. So, you start small, and you build up on that. It is not an overnight fix; it is a slow and steady progress.”
Nursing education should be viewed as a long-course endeavor rather than a sprint.
Alyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Understanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.
Kellie Zeichner BSN, RN, OCN, explains how her institution created a standardized monitoring procedure for insulinoma care.
Although the CDC has put forth a strong effort to improve its opioid guidelines, many providers still feel that more can be done.
Laurel Sopher was diagnosed with breast cancer while pregnant at 15 weeks. Laurel's son, Alexander, was born in 2000. Laurel also delivered twin boys in 2004.
Chemotherapy education is a puzzle personalized for each patient. Each piece of the puzzle represents a different method of instruction to supplement nurses’ interpersonal teaching.
Breast cancer is the leading cause of cancer deaths among Black women of all ages and is increasing in younger women in the U.S.
Sandra Spoelstra, PhD, RN, of the Michigan State University College of Nursing, outlines the essential and growing role of oncology nurses in helping patients with cancer to manage their oral regimens
When considering the importance of medication adherence, former US Surgeon General C. Everett Koop said it best: “Drugs don’t work in patients who don’t take them.” That was 35 years ago, and the issue remains a major area of concern for clinicians today.
Howard Cohen, RPh, MS, FASHP, director of oncology pharmacy services, Smilow Cancer Center, Yale New Haven Health, discusses the challenges of cancer treatment from a pharmacy perspective.